Aliment. Pharmacol. Ther.

Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis.

Mücke MM, Hernández-Tejero M, Gu W, ..., Trebicka J, MICROB-PREDICT and PREDICT Study Group of the EASL-CLIF Consortium

Aliment. Pharmacol. Ther. 59 (7) 877-888 [2024-04-00; online 2024-02-27]

Letter: safety of proton pump inhibitors during pregnancy-authors' reply.

Mei Li C, Brusselaers N

Aliment. Pharmacol. Ther. 52 (4) 740-741 [2020-08-00; online 2020-09-05]

Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy.

Li CM, Zhernakova A, Engstrand L, Wijmenga C, Brusselaers N

Aliment. Pharmacol. Ther. 51 (4) 410-420 [2020-02-00; online 2020-01-07]

Letter: dose-response analysis revealed closer relationship between obesity and perioperative outcomes in patients after liver transplantation.

Liu Z, Mardinoglu A, Que S

Aliment. Pharmacol. Ther. 47 (2) 310-312 [2018-01-00; online 2017-12-22]

Adil Mardinoglu SciLifeLab Fellow